5519W-13: Mease Pfizer A3921092

Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis (OPAL BALANCE)

Type of Study
Rheumatology - Psoriatic Arthritis
Short Description
This is a Phase 3, long-term open-label extension study to evaluate the safety, tolerability and efficacy of tofacitinib in subjects with active PsA who have previously participated in randomized studies of tofacitinib for this indication.
Status
Open
Principal Investigator
Philip J. Mease, MD
Start Date
1/23/2014
Contact Name
Allison Everett
Phone
206-386-3201
Alternate Phone
206-386-6248
Email
Allison.Everett@swedish.org
Alternate Email
Sephren.Barrow@swedish.org